Cargando…
New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
An increasing body of evidence suggests that the long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) combination appears to play an important role in maximizing bronchodilation, with studies to date indicating that combining different classes of bronchodilators may result in sig...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797618/ https://www.ncbi.nlm.nih.gov/pubmed/24143077 http://dx.doi.org/10.2147/DDDT.S39449 |